National and Kapodistrian University of Athens
Η ΣΥΜΒΟΛΗ ΤΟΥ G-CSF ΣΤΗΝ ΑΝΤΙΜΕΤΩΠΙΣΗ ΤΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΜΑΣΤΟΥ ΜΕ ΥΨΗΛΕΣ ΔΟΣΕΙΣ ΧΗΜΕΙΟΘΕΡΑΠΕΙΑΣ. ΚΛΙΝΙΚΕΣ ΚΑΙ ΠΑΡΑΚΛΙΝΙΚΕΣ ΠΑΡΑΜΕΤΡΟΙ
Abstract
dc:descriptionFIFTY TWO PATIENTS WITH METASTATIC BREAST CANCER WERE TREATED WITH 110 MG /M2 EPIRUBICIN EVERY 4 WEEKS UP TO A TOTAL OF 6 CYCLES. OVERALL RESPONSE RATE WAS 35% WITH 6% COMPLETE RESPONSE. MEDIAN SURVIVAL WAS 31 WEEKS WITH 54, 76 AND 77WEEKS IN COMPLETE RESPONDERS. TIME TO PROGRESSION WAS 28, 37 AND 77 WEEKS IN COMPLETE RESPONDERS. MEDIAN TIME TO PROGRESSION WAS 34 WEEKS IN PARTIAL RESPONDERS AND 23 WEEKS IN PATIENTS WITH STABLE DISEASE. TOXICITY, INCLUDING MYELOSUPPRESSION, INFECTIONS WHICH NEEDED HOSPITALISATION AND MYCOSITIS WAS FREQUENT AND SERIOUS. A SECOND GROUP CONSISTING OF 42 WOMEN, ENTERED THE SAME PROTOCOL.USING G-CSF AS ADJUNCT IT WAS FEASIBLE TO DELIVER THE 99.6% OF THE PROTOCOL DOSE. RESPONSE RATE, SURVIVAL AND MEDIAN TIME TO PROGRESSION DID NOT DIFFER SIGNIFICANTLY WITH PREVIOUS STUDY. HOWEVER TOXICITY WAS NEGLIGIBLE IF COMPARED TOPREVIOUS STUDY WITHOUT G-CSF.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 1993
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Christodoulou, Christos
- Χριστοδούλου, Χρήστος
Subjects
dc:subject × 14- ΑΥΞΗΤΙΚΟΣ ΠΑΡΑΓΩΝ ΑΠΟΙΚΙΩΝ ΚΟΚΚΙΟΚΥΤΤΑΡΩΝ (G-CSF)
- ΕΝΤΑΤΙΚΟΠΟΙΗΣΗ ΧΗΜΕΙΟΘΕΡΑΠΕΙΑΣ
- ΕΠΙΡΟΥΒΙΚΙΝΗ - ΑΝΘΡΑΚΥΚΛΙΝΗ
- Καρκίνος του μαστού ( Μεταστατικός)
- ΥΨΗΛΕΣ ΔΟΣΕΙΣ ΧΗΜΕΙΟΘΕΡΑΠΕΙΑΣ
- Breast cancer (metastatic)
- DOSE INDENSIFICATION
- EPIRUBICIN - ANTHRACYCLINES
- Granulocyte colony stimulating factor (G-CSF)
- HIGH DOSE CHEMOTHERAPY
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/5382